TR201100152A2 - Amlodipin içeren efervesan bileşimler. - Google Patents

Amlodipin içeren efervesan bileşimler.

Info

Publication number
TR201100152A2
TR201100152A2 TR2011/00152A TR201100152A TR201100152A2 TR 201100152 A2 TR201100152 A2 TR 201100152A2 TR 2011/00152 A TR2011/00152 A TR 2011/00152A TR 201100152 A TR201100152 A TR 201100152A TR 201100152 A2 TR201100152 A2 TR 201100152A2
Authority
TR
Turkey
Prior art keywords
compositions containing
effervescent compositions
containing amlodipine
amlodipine
effervescent
Prior art date
Application number
TR2011/00152A
Other languages
English (en)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2011/00152A priority Critical patent/TR201100152A2/tr
Priority to PCT/TR2012/000002 priority patent/WO2012093971A2/en
Publication of TR201100152A2 publication Critical patent/TR201100152A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Mevcut buluş, amlodipin veya farmasötik açıdan uygun herhangi bir türevini içeren stabilitesi geliştirilmiş, kullanımı kolay efervesan formülasyonlara ve bu formülasyonun hipertansiyon tedavisinde kullanımına ilişkindir.
TR2011/00152A 2011-01-06 2011-01-06 Amlodipin içeren efervesan bileşimler. TR201100152A2 (tr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2011/00152A TR201100152A2 (tr) 2011-01-06 2011-01-06 Amlodipin içeren efervesan bileşimler.
PCT/TR2012/000002 WO2012093971A2 (en) 2011-01-06 2012-01-06 Effervescent compositions comprising amlodipine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2011/00152A TR201100152A2 (tr) 2011-01-06 2011-01-06 Amlodipin içeren efervesan bileşimler.

Publications (1)

Publication Number Publication Date
TR201100152A2 true TR201100152A2 (tr) 2012-07-23

Family

ID=45855989

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2011/00152A TR201100152A2 (tr) 2011-01-06 2011-01-06 Amlodipin içeren efervesan bileşimler.

Country Status (2)

Country Link
TR (1) TR201100152A2 (tr)
WO (1) WO2012093971A2 (tr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104055742B (zh) * 2014-02-13 2018-01-19 合肥九研医药科技开发有限公司 苯磺酸左旋氨氯地平药物组合物及其制备方法
CN105310992B (zh) * 2015-10-16 2018-11-09 施慧达药业集团(吉林)有限公司 苯磺酸左旋氨氯地平盐水合物的片剂组合物、由其制成的片剂及相关制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161312C (da) 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
IT1255792B (it) * 1992-08-05 1995-11-16 Bayer Italia Spa Composizioni farmaceutiche per la somministrazione orale di diidropiridine in forma di bevanda
IE940292A1 (en) * 1994-04-06 1995-10-18 Elan Corp Plc Biodegradable microcapsules and method for their manufacture
WO2000057857A1 (en) * 1999-03-25 2000-10-05 Yuhan Corporation Rapidly disintegrable tablet for oral administration
WO2006070845A1 (ja) * 2004-12-28 2006-07-06 Eisai R & D Management Co., Ltd. 速崩壊性錠剤及びその製造方法
EP2575757A1 (en) * 2010-06-03 2013-04-10 Mahmut Bilgic Water soluble formulation comprising a combination of amlodipine and a statin

Also Published As

Publication number Publication date
WO2012093971A3 (en) 2012-09-20
WO2012093971A2 (en) 2012-07-12

Similar Documents

Publication Publication Date Title
CY1122853T1 (el) Σταθερα σκευασματα λινακλοτιδης
DOP2011000354A (es) Composiciones sublinguales de dexmedetomidina y metodos de uso de ellas
PH12015501439A1 (en) Oral care products comprising zinc oxide and trimethylglycine
EA201390803A1 (ru) Ингибиторы бромодомена и их применение
MX2011003473A (es) Composiciones para el cuidado bucal.
MA33803B1 (fr) Inhibiteur de bromodomaine de benzodiazépine
EP2550954A4 (en) VASELINOUS COMPOSITION AND COSMETIC PREPARATION THEREOF
MX2012007164A (es) Composiciones para el cuidado oral.
EA201270741A1 (ru) Пероральные композиции и липофильные соли метилналтрексона
MX2019012939A (es) Formulaciones que contienen linaclotida para administracion oral.
MY161595A (en) Oral care compositions
EA201390799A1 (ru) Триазолопиридины
PH12012501620A1 (en) Oral care compositions
EA201590491A1 (ru) Иммуногенная композиция
TR201906685T4 (tr) Kristalin macitentan içeren farmasötik bileşim.
EA201201109A1 (ru) Прасугрель в тонкоизмельченной кристаллической форме и фармацевтическая композиция, содержащая его
TR201009394A2 (tr) Geliştirilmiş montelukast formülasyonları.
MA32321B1 (fr) Pregn-4-en-21, 17 carbolactones substitués sur le noyau c, et préparations pharmaceutiques contenant ces derniers
UA109804C2 (xx) 2-метоксипіридин-4-ільні похідні
TR201803451T4 (tr) Olmesartan formülasyonlari.
TR201100152A2 (tr) Amlodipin içeren efervesan bileşimler.
TR200909785A1 (tr) Aktif ajan olarak sefdinir içeren farmasötik kompozisyonlar.
EA201291420A1 (ru) Пероральные лекарственные формы, содержащие лерканидипин и эналаприл и их фармацевтически приемлемые соли
TR201005327A2 (tr) Sinerjik farmasötik formülasyonlar.
MX2013008559A (es) Derivados de leptina.